Vitality Watch

Dossier clinicaltrials observational 10-nov-2026
Human cohort, case-control, or epidemiological association

Sarcopenic Obesity: Estimation of Prevalence and Identification of Clinical and Biological Determinants in a Population of Adult Obese Patients

Key claim: An observational study protocol investigates the prevalence, clinical risk factors, and specific plasma and urinary biomarkers of sarcopenic obesity in adults aged 18 to 70.

Abstract

This project aims first to determine the prevalence of sarcopenia in a population of obese people of extended age group (18-70 years). In a second step, the factors determining and / or predisposing to sarcopenic obesity will be identified as well as plasmatic and urinary biomarkers specific to this phenotype.

Why this matters

An observational study protocol investigates the prevalence, clinical risk factors, and specific plasma and urinary biomarkers of sarcopenic obesity in adults aged 18 to 70.

Source

Link

Briefing card

Sarcopenic Obesity: Estimation of Prevalence and Identification of Clinical and Biological Determinants in a Population of Adult Obese Patients
Stage: observational · clinicaltrials · 10-nov-2026

An observational study protocol investigates the prevalence, clinical risk factors, and specific plasma and urinary biomarkers of sarcopenic obesity in adults aged 18 to 70.

Cross-references (0)

None recorded — doctrine links and citations appear here as scans and citation sweeps find them.

External: nct:NCT03394469

build build 880 · 2bcef25 · 2026-11-18